Publication:
Review of mass drug administration for malaria and its operational challenges

dc.contributor.authorGretchen Newbyen_US
dc.contributor.authorJimee Hwangen_US
dc.contributor.authorKadiatou Koitaen_US
dc.contributor.authorIngrid Chenen_US
dc.contributor.authorBrian Greenwooden_US
dc.contributor.authorLorenz Von Seidleinen_US
dc.contributor.authorG. Dennis Shanksen_US
dc.contributor.authorLaurence Slutskeren_US
dc.contributor.authorS. Patrick Kachuren_US
dc.contributor.authorJennifer Wegbreiten_US
dc.contributor.authorMatthew M. Ippolitoen_US
dc.contributor.authorEugenie Poiroten_US
dc.contributor.authorRoly Goslingen_US
dc.contributor.otherUniversity of California, San Franciscoen_US
dc.contributor.otherLondon School of Hygiene & Tropical Medicineen_US
dc.contributor.otherMahidol Universityen_US
dc.contributor.otherAustralian Army Malaria Instituteen_US
dc.contributor.otherCenters for Disease Control and Preventionen_US
dc.contributor.otherJohns Hopkins Universityen_US
dc.date.accessioned2018-11-23T10:21:51Z
dc.date.available2018-11-23T10:21:51Z
dc.date.issued2015-01-01en_US
dc.description.abstractCopyright © 2015 by The American Society of Tropical Medicine and Hygiene. Mass drug administration (MDA) was a component of many malaria programs during the eradication era, but later was seldomly deployed due to concerns regarding efficacy and feasibility and fear of accelerating drug resistance. Recently, however, there has been renewed interest in the role of MDA as an elimination tool. Following a 2013 Cochrane Review that focused on the quantitative effects of malaria MDA, we have conducted a systematic, qualitative review of published, unpublished, and gray literature documenting past MDA experiences. We have also consulted with field experts, using their historical experience to provide an informed, contextual perspective on the role of MDA in malaria elimination. Substantial knowledge gaps remain and more research is necessary, particularly on optimal target population size, methods to improve coverage, and primaquine safety. Despite these gaps, MDA has been used successfully to control and eliminate Plasmodium falciparum and P. vivax malaria in the past, and should be considered as part of a comprehensive malaria elimination strategy in specific settings.en_US
dc.identifier.citationAmerican Journal of Tropical Medicine and Hygiene. Vol.93, No.1 (2015), 125-134en_US
dc.identifier.doi10.4269/ajtmh.14-0254en_US
dc.identifier.issn00029637en_US
dc.identifier.other2-s2.0-84936991079en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/36172
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84936991079&origin=inwarden_US
dc.subjectImmunology and Microbiologyen_US
dc.titleReview of mass drug administration for malaria and its operational challengesen_US
dc.typeReviewen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84936991079&origin=inwarden_US

Files

Collections